Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
83 | Current Computer-Aided Drug Design | journal | 0.283 Q3 | 32 | 36 | 197 | 1766 | 365 | 191 | 1.76 | 49.06 | 38.22 | |
82 | Egyptian Journal of Chemistry | journal | 0.284 Q3 | 29 | 540 | 2216 | 24764 | 3198 | 2216 | 1.29 | 45.86 | 46.71 | |
81 | Current Medical Imaging | journal | 0.288 Q3 | 37 | 184 | 517 | 7302 | 731 | 499 | 1.25 | 39.68 | 33.63 | |
80 | Qatar Medical Journal | journal | 0.295 Q3 | 14 | 36 | 177 | 906 | 197 | 170 | 0.96 | 25.17 | 37.67 | |
79 | Open AIDS Journal | journal | 0.297 Q3 | 22 | 11 | 35 | 361 | 27 | 34 | 0.84 | 32.82 | 41.18 | |
78 | Combinatorial Chemistry and High Throughput Screening | journal | 0.301 Q3 | 70 | 215 | 504 | 12432 | 828 | 472 | 1.71 | 57.82 | 43.80 | |
77 | Prostate Cancer | journal | 0.305 Q3 | 15 | 2 | 33 | 99 | 37 | 33 | 0.76 | 49.50 | 40.00 | |
76 | Egyptian Rheumatologist | journal | 0.328 Q3 | 21 | 62 | 192 | 2194 | 225 | 191 | 1.10 | 35.39 | 69.53 | |
75 | Reviews on Recent Clinical Trials | journal | 0.331 Q3 | 35 | 36 | 139 | 1393 | 184 | 123 | 1.51 | 38.69 | 42.86 | |
74 | Infectious Disorders - Drug Targets | journal | 0.338 Q3 | 61 | 89 | 374 | 4320 | 542 | 350 | 1.47 | 48.54 | 42.90 | |
73 | Annals of Saudi Medicine | journal | 0.343 Q3 | 54 | 49 | 176 | 1282 | 264 | 165 | 1.50 | 26.16 | 41.43 | |
72 | Open Cardiovascular Medicine Journal | journal | 0.348 Q3 | 32 | 4 | 29 | 307 | 23 | 26 | 0.33 | 76.75 | 36.36 | |
71 | Journal of Skin Cancer | journal | 0.350 Q3 | 15 | 2 | 32 | 39 | 47 | 32 | 1.46 | 19.50 | 50.00 | |
70 | Current Drug Safety | journal | 0.352 Q3 | 41 | 83 | 127 | 2789 | 177 | 124 | 1.10 | 33.60 | 45.66 | |
69 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.356 Q3 | 43 | 24 | 64 | 958 | 90 | 56 | 1.28 | 39.92 | 43.10 | |
68 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.361 Q3 | 27 | 23 | 93 | 1583 | 149 | 88 | 1.15 | 68.83 | 60.40 | |
67 | International Journal of Vascular Medicine | journal | 0.376 Q3 | 34 | 2 | 35 | 88 | 60 | 35 | 2.44 | 44.00 | 27.27 | |
66 | Saudi Medical Journal | journal | 0.379 Q3 | 63 | 208 | 635 | 5085 | 826 | 559 | 1.25 | 24.45 | 37.50 | |
65 | Current Rheumatology Reviews | journal | 0.384 Q3 | 29 | 63 | 154 | 2741 | 184 | 149 | 1.11 | 43.51 | 56.54 | |
64 | Sultan Qaboos University Medical Journal | journal | 0.386 Q3 | 35 | 110 | 297 | 2249 | 373 | 245 | 1.18 | 20.45 | 42.28 | |
63 | Health Professions Education | journal | 0.407 Q3 | 22 | 27 | 84 | 821 | 151 | 77 | 0.00 | 30.41 | 46.32 | |
62 | International Journal of Hepatology | journal | 0.417 Q3 | 20 | 8 | 36 | 237 | 68 | 36 | 1.38 | 29.63 | 35.56 | |
61 | Middle East Fertility Society Journal | journal | 0.417 Q3 | 26 | 33 | 112 | 1368 | 203 | 110 | 1.71 | 41.45 | 53.08 | |
60 | Occupational Therapy International | journal | 0.421 Q3 | 45 | 37 | 123 | 1620 | 219 | 123 | 1.67 | 43.78 | 72.79 | |
59 | International Journal of Pediatrics and Adolescent Medicine | journal | 0.422 Q2 | 14 | 0 | 139 | 0 | 247 | 137 | 1.35 | 0.00 | 0.00 | |
58 | Advances in Orthopedics | journal | 0.438 Q3 | 23 | 25 | 108 | 816 | 159 | 108 | 1.39 | 32.64 | 20.65 | |
57 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.440 Q3 | 49 | 21 | 98 | 1935 | 184 | 92 | 1.29 | 92.14 | 49.25 | |
56 | Rehabilitation Research and Practice | journal | 0.440 Q2 | 13 | 4 | 51 | 201 | 101 | 51 | 1.55 | 50.25 | 55.56 | |
55 | International Journal of Breast Cancer | journal | 0.443 Q3 | 23 | 7 | 48 | 302 | 93 | 48 | 1.76 | 43.14 | 44.74 | |
54 | Recent advances in inflammation & allergy drug discovery | journal | 0.443 Q3 | 37 | 19 | 42 | 1111 | 84 | 35 | 0.86 | 58.47 | 35.14 | |
53 | Current Neurovascular Research | journal | 0.461 Q3 | 60 | 53 | 207 | 2942 | 435 | 192 | 1.80 | 55.51 | 39.10 | |
52 | Anesthesiology Research and Practice | journal | 0.472 Q2 | 28 | 17 | 84 | 604 | 143 | 84 | 1.50 | 35.53 | 29.17 | |
51 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.495 Q3 | 63 | 177 | 557 | 10866 | 1227 | 539 | 2.06 | 61.39 | 48.13 | |
50 | Current Aging Science | journal | 0.505 Q3 | 42 | 28 | 75 | 1742 | 180 | 72 | 1.82 | 62.21 | 46.67 | |
49 | Anemia | journal | 0.524 Q3 | 31 | 7 | 48 | 218 | 106 | 48 | 2.00 | 31.14 | 29.63 | |
48 | Current Stem Cell Research and Therapy | journal | 0.525 Q2 | 63 | 100 | 203 | 7644 | 476 | 194 | 2.12 | 76.44 | 45.59 | |
47 | Scientific World Journal, The | journal | 0.526 Q2 | 127 | 97 | 527 | 4823 | 1847 | 527 | 2.87 | 49.72 | 42.12 | |
46 | Current Protein and Peptide Science | journal | 0.527 Q2 | 96 | 69 | 252 | 5886 | 615 | 237 | 1.95 | 85.30 | 41.45 | |
45 | Journal of the Egyptian National Cancer Institute | journal | 0.537 Q3 | 28 | 43 | 142 | 1859 | 324 | 140 | 1.99 | 43.23 | 42.36 | |
44 | Journal of Nutrition and Metabolism | journal | 0.540 Q3 | 57 | 19 | 207 | 842 | 527 | 207 | 2.51 | 44.32 | 57.89 | |
43 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.540 Q2 | 52 | 41 | 103 | 3859 | 252 | 100 | 2.51 | 94.12 | 48.44 | |
42 | Oman Medical Journal | journal | 0.541 Q2 | 46 | 126 | 359 | 2902 | 643 | 284 | 1.16 | 23.03 | 47.38 | |
41 | Current Radiopharmaceuticals | journal | 0.542 Q2 | 32 | 35 | 103 | 1937 | 170 | 92 | 1.29 | 55.34 | 43.71 | |
40 | Current Genomics | journal | 0.543 Q3 | 77 | 33 | 152 | 1866 | 381 | 135 | 1.91 | 56.55 | 44.36 | |
39 | Current Topics in Medicinal Chemistry | journal | 0.549 Q2 | 133 | 177 | 640 | 18576 | 1720 | 515 | 2.52 | 104.95 | 41.01 | |
38 | Advances in Hematology | journal | 0.553 Q3 | 38 | 8 | 44 | 213 | 68 | 44 | 1.37 | 26.63 | 50.00 | |
37 | Dermatology Research and Practice | journal | 0.553 Q2 | 38 | 12 | 74 | 377 | 165 | 74 | 1.39 | 31.42 | 60.53 | |
36 | Canadian Respiratory Journal | journal | 0.555 Q2 | 63 | 31 | 189 | 975 | 438 | 186 | 2.07 | 31.45 | 46.49 | |
35 | Recent patents on food, nutrition & agriculture | journal | 0.555 Q2 | 33 | 0 | 42 | 0 | 143 | 39 | 1.21 | 0.00 | 0.00 | |
34 | Autoimmune Diseases | journal | 0.556 Q3 | 41 | 1 | 19 | 30 | 57 | 19 | 1.57 | 30.00 | 66.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®